| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |